Prof Colin Masters on ABC National Radio
ADNeT Screening and Trials Co-Lead, Professor Colin Masters, spoke on ABC National Radio with presenter Patricia Karvelas about the groundbreaking findings from Phase 3 TRAILBLAZER-ALZ-2 study on new Alzheimer’s drug donanemab.